Cargando…

Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer

The potential use of agomelatine as an alternative treatment for colorectal cancer is evaluated in this work. The effect of agomelatine was studied in an in vitro model using two cell lines with different p53 statuses (HCT-116, wild-type p53, and HCT-116 p53 null) and an in vivo xenograft model. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno-SanJuan, Sara, Puentes-Pardo, Jose D., Casado, Jorge, Escudero-Feliu, Julia, Khaldy, Huda, Arnedo, Javier, Carazo, Ángel, León, Josefa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135458/ https://www.ncbi.nlm.nih.gov/pubmed/37107301 http://dx.doi.org/10.3390/antiox12040926

Ejemplares similares

Core Circadian Clock Proteins as Biomarkers of Progression in Colorectal Cancer
por: Aroca-Siendones, María I., et al.
Publicado: (2021)

PARP-1 Expression Influences Cancer Stem Cell Phenotype in Colorectal Cancer Depending on p53
por: Puentes-Pardo, Jose D., et al.
Publicado: (2023)

Heme Oxygenase-1 in Gastrointestinal Tract Health and Disease
por: Puentes-Pardo, Jose D., et al.
Publicado: (2020)

Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53
por: Ríos-Arrabal, Sandra, et al.
Publicado: (2021)

Circadian Genes as Therapeutic Targets in Pancreatic Cancer
por: García-Costela, María, et al.
Publicado: (2020)

Narrow Leafed Lupin (Lupinus angustifolius L.) β-Conglutin Seed Proteins as a New Natural Cytotoxic Agents against Breast Cancer Cells
por: Escudero-Feliu, Julia, et al.
Publicado: (2023)

In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
por: Lopez-Perez, David, et al.
Publicado: (2021)

The effect of agomelatine and melatonin on sleep-related eating: a case report
por: Zapp, Angela Alexandra, et al.
Publicado: (2017)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2022)

Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Human adipose tissue as a major reservoir of cytomegalovirus-reactive T cells
por: Redruello-Romero, Anaïs, et al.
Publicado: (2023)

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells
por: Yao, Kai, et al.
Publicado: (2019)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors
por: Casado, Jorge, et al.
Publicado: (2017)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Indirect autonomic nervous system activity assessment with heart rate variability in rats with cyclophosphamide-induced hemorrhagic cystitis treated with melatonin or agomelatine
por: Dobrek, Łukasz, et al.
Publicado: (2015)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study
por: Robillard, Rebecca, et al.
Publicado: (2018)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
por: Rami, Marouan, et al.
Publicado: (2012)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRI
por: Lopez-Perez, David, et al.
Publicado: (2022)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells
por: Cheng, Fang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_724mp7ctutm7iv2bcgllm36bos